Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH16410 vs Rosuvastatin and Telmisartan in Hypertension and Hyperlipidemia
NCT01914432Phase 3Completed
- Sponsor
- Yuhan
- Start
- Nov 2013
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan, rosuvastatin in hypertension (HTN), hyperlipidemia, sponsored by Yuhan. Started Nov 2013; status: completed.
02
Drugs
telmisartanrosuvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT01914432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914432.